Agenus Inc. (AGEN) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
3 FORBES ROAD LEXINGTON, MA 02421 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 40,400 | 76,100 | 193,400 | 306,900 | 99,871 | 61,808 | |||
| Cash and cash equivalent | 40,437 | 76,110 | 178,674 | 291,931 | 99,871 | 61,808 | |||
| Short-term investments | 14,684 | 14,992 | |||||||
| Other undisclosed cash, cash equivalents, and short-term investments | (37) | (10) | 42 | (23) | |||||
| Receivables | 407 | 25,836 | 2,741 | 1,518 | 1,157 | 16,293 | |||
| Prepaid expense | 2,315 | 8,098 | 13,829 | 20,362 | 10,746 | 7,420 | |||
| Asset, held-for-sale, not part of disposal group | |||||||||
| Other current assets | 2,415 | 2,372 | 3,194 | 3,171 | 2,009 | 1,015 | |||
| Other undisclosed current assets | 37 | 10 | (42) | 23 | |||||
| Total current assets: | 45,574 | 112,416 | 213,122 | 331,974 | 113,783 | 86,536 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | |||||||||
| Operating lease, right-of-use asset | 27,308 | 29,606 | 31,269 | 31,054 | 33,480 | 7,364 | |||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 120,087 | 133,421 | 133,017 | 60,029 | 26,790 | 26,326 | |||
| Long-term investments and receivables | |||||||||
| Long-term investments | |||||||||
| Intangible asset, including goodwill, after accumulated amortization | 27,468 | 29,134 | 31,695 | 33,364 | 36,338 | 33,692 | |||
| Goodwill | 24,092 | 24,723 | 25,467 | 24,876 | 25,452 | 23,188 | |||
| Intangible asset, excluding goodwill, after accumulated amortization | 3,376 | 4,411 | 6,228 | 8,488 | 10,886 | 10,504 | |||
| Other noncurrent assets | 5,834 | 9,336 | 4,453 | 9,537 | 4,123 | 1,417 | |||
| Other undisclosed noncurrent assets | |||||||||
| Total noncurrent assets: | 180,697 | 201,497 | 200,434 | 133,984 | 100,731 | 68,799 | |||
| TOTAL ASSETS: | 226,271 | 313,913 | 413,556 | 465,958 | 214,514 | 155,335 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 96,431 | 106,729 | 79,198 | 72,577 | 46,072 | 44,896 | |||
| Accounts payable | 61,470 | 61,446 | 40,939 | 30,486 | 17,015 | 13,564 | |||
| Accrued liabilities | 34,961 | 45,283 | 38,259 | 42,091 | 29,057 | 31,332 | |||
| Deferred revenue | 31 | 18 | 12,269 | 12,425 | 17,186 | 29,174 | |||
| Debt | 2,698 | 146 | 8,527 | 1,063 | 1,579 | 2,141 | |||
| Disposal group, including discontinued operation | |||||||||
| Other liabilities | 7,817 | 13,915 | 11,457 | 6,546 | 6,481 | 185 | |||
| Other undisclosed current liabilities | 114,424 | 135,089 | 77,501 | 64,332 | 58,566 | 45,813 | |||
| Total current liabilities: | 221,401 | 255,897 | 188,952 | 156,943 | 129,884 | 122,209 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 30,588 | 17,487 | 24,854 | 55,250 | 53,010 | 21,400 | |||
| Long-term debt, excluding current maturities | 30,473 | 12,768 | 12,584 | 12,823 | 18,879 | 13,380 | |||
| Finance lease, liability | 115 | 4,719 | 12,270 | 318 | 66 | ||||
| Liabilities, other than long-term debt | 56,432 | 69,074 | 79,169 | 14,466 | 40,004 | 40,738 | |||
| Deferred revenue | 1,143 | 1,143 | 1,143 | 11,200 | 28,282 | 27,705 | |||
| Other liabilities | 738 | 5,420 | 13,826 | 1,577 | 1,514 | 4,190 | |||
| Operating lease, liability | 54,551 | 62,511 | 63,326 | 42,109 | 34,065 | 8,020 | |||
| Business combination, contingent consideration, liability | 874 | 1,689 | 10,208 | 8,843 | |||||
| Other undisclosed noncurrent liabilities | 224,274 | 119,837 | 175,483 | 191,390 | 203,114 | 202,325 | |||
| Total noncurrent liabilities: | 311,294 | 206,398 | 279,506 | 261,106 | 296,128 | 264,463 | |||
| Total liabilities: | 532,695 | 462,295 | 468,458 | 418,049 | 426,012 | 386,672 | |||
| Equity | |||||||||
| Equity, attributable to parent | (326,380) | (160,331) | (61,278) | 34,440 | (203,672) | (225,356) | |||
| Common stock | 236 | 3,944 | 3,056 | 2,569 | 1,961 | 1,378 | |||
| Additional paid in capital | 1,857,662 | 1,792,348 | 1,644,658 | 1,520,212 | 1,257,502 | 1,059,583 | |||
| Accumulated other comprehensive income (loss) | (1,398) | (955) | 915 | 1,492 | 2,772 | (1,324) | |||
| Accumulated deficit | (2,182,880) | (1,955,668) | (1,709,907) | (1,489,833) | (1,465,907) | (1,284,993) | |||
| Equity, attributable to noncontrolling interest | 19,956 | 11,949 | 6,376 | 13,469 | (7,826) | (5,981) | |||
| Total equity: | (306,424) | (148,382) | (54,902) | 47,909 | (211,498) | (231,337) | |||
| TOTAL LIABILITIES AND EQUITY: | 226,271 | 313,913 | 413,556 | 465,958 | 214,514 | 155,335 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 103,463 | 156,314 | 98,024 | 295,665 | 88,170 | 150,048 | ||
| Cost of revenue | (486) | (3,111) | (10,568) | (3,470) | (2,349) | |||
| Gross profit: | 102,977 | 153,203 | 87,456 | 292,195 | 85,821 | 150,048 | ||
| Operating expenses | (255,847) | (313,308) | (267,698) | (254,967) | (201,835) | (214,380) | ||
| Other undisclosed operating income (loss) | 32,395 | 556 | 815 | (11,481) | (1,221) | (5,805) | ||
| Operating income (loss): | (120,475) | (159,549) | (179,427) | 25,747 | (117,235) | (70,137) | ||
| Nonoperating income (expense) | 5,830 | 37 | 12,571 | 5,051 | (1,858) | 28 | ||
| Investment income, nonoperating | 2,795 | |||||||
| Gain (loss), foreign currency transaction, before tax | (29) | (100) | (400) | 1,000 | (3,100) | 100 | ||
| Other nonoperating income | 5,830 | |||||||
| Interest and debt expense | (120,421) | 6,197 | ||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (235,066) | (159,512) | (166,856) | 36,995 | (119,093) | (70,109) | ||
| Loss from equity method investments | ||||||||
| Other undisclosed income from continuing operations before income taxes | ||||||||
| Income (loss) from continuing operations: | (235,066) | (159,512) | (166,856) | 36,995 | (119,093) | (70,109) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | 36,995 | (119,093) | (70,109) | |
| Other undisclosed net income (loss) | 2,795 | (97,925) | (63,800) | (65,719) | (63,798) | (41,451) | ||
| Net loss: | (232,271) | (257,437) | (230,656) | (28,724) | (182,891) | (111,560) | ||
| Net income attributable to noncontrolling interest | 5,059 | 11,676 | 10,582 | 4,798 | 1,977 | 3,903 | ||
| Net income (loss) attributable to parent: | (227,212) | (245,761) | (220,074) | (23,926) | (180,914) | (107,657) | ||
| Preferred stock dividends and other adjustments | (215) | (213) | (212) | (211) | (209) | (208) | ||
| Other undisclosed net income available to common stockholders, basic | 0 | |||||||
| Net loss available to common stockholders, diluted: | (227,427) | (245,974) | (220,286) | (24,137) | (181,123) | (107,865) | ||
Comprehensive Income ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (232,271) | (257,437) | (230,656) | (28,724) | (182,891) | (111,560) | ||
| Other comprehensive income (loss) | (443) | (1,870) | (577) | (1,280) | 4,096 | 215 | ||
| Comprehensive loss: | (232,714) | (259,307) | (231,233) | (30,004) | (178,795) | (111,345) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 5,059 | 11,676 | 10,582 | 4,798 | 1,977 | 3,903 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (227,655) | (247,631) | (220,651) | (25,206) | (176,818) | (107,442) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.